Skip to content

Transatlantic health technology fund debuts, a pioneering initiative by Meridan Health Ventures

Transatlantic Fund Launched by Meridian Health Ventures for Health Technology Giants to Expand Globally and Domestically

Investment firm Meridan Health Ventures unveils the inaugural transatlantic fund for healthcare...
Investment firm Meridan Health Ventures unveils the inaugural transatlantic fund for healthcare technology, touted as the global first.

Transatlantic health technology fund debuts, a pioneering initiative by Meridan Health Ventures

Meridian Health Ventures Launches Transatlantic Fund for HealthTech Innovation

In a significant move to boost HealthTech innovation across Europe and North America, Meridian Health Ventures, formerly known as KHP Ventures, has announced the launch of a transatlantic fund. The €44 million fund aims to support and scale startups developing transformative healthcare solutions by leveraging cross-border opportunities and expertise.

The fund, which is the world's first transatlantic HealthTech fund, strategically targets companies that can benefit from combined market access and collaboration between the UK/Europe and the US. This move is expected to create an environment where ambitious founders can scale at pace, both domestically and internationally.

Alex Trewby, CEO and Co-Founder of Apian, a company in Meridian Health Ventures' portfolio, expressed his gratitude for the support from Meridian Health Ventures and Trusts like Guy's and St Thomas' NHS Foundation Trust. Apian's mission has a global reach, with work done with Zipline and Wing, and care delivered to patients faster.

The fund's partners include leading health systems, venture investors, institutional investors, and academic centres of excellence. Notable partners include Guy's and St Thomas' NHS Foundation Trust, King's College Hospital, University College London Hospitals, Cedars-Sinai Medical Center, and Hartford HealthCare. Cedars-Sinai sees the partnership as deeply aligned with its mission to provide patients around the world with the best care possible.

Several companies in the fund's portfolio are already working with US health system partners, such as Cedars-Sinai. The fund's goal is to supercharge the growth of promising innovations for direct benefits to the NHS's patients and workforce, as well as the wider UK economy.

The team behind Meridian Health Ventures consists of entrepreneurs, investors, operators, regulators, industry leaders, academics, and clinicians. The fund has invested in MedTech spin-outs from Cambridge, Oxford, Imperial, King's, and Southampton, with 12 NHS clinical entrepreneurs among its company founders.

The fund's portfolio includes companies such as Doccla, deepc, Patchwork, Tympa Health, Apian, iFAST Diagnostics, PocDoc, Phare Health, 52 North, and MediShout. The fund brings together the best of both continents to help healthtech superscalers thrive domestically in the UK and fast-track their growth in the US.

The partners in the fund will enable start-ups to generate real-world data and evidence for adoption within broader UK and US healthcare environments. The fund's partners are committed to harnessing accelerations in new digital and biomedical advances to deliver better, faster, and fairer healthcare for all.

With the launch of this transatlantic fund, Meridian Health Ventures hopes to play a pivotal role in fostering innovation in healthcare technologies, ultimately benefiting patients and the wider healthcare ecosystem across Europe and North America. The fund was founded in 2021.

  1. The health tech industry is poised for significant growth with the launch of Meridian Health Ventures' transatlantic fund.
  2. This €44 million fund aims to strengthen startups in the digital health sector, focusing on innovative healthcare solutions.
  3. Meridian Health Ventures, previously known as KHP Ventures, embarks on this venture with a strategic goal to leverage cross-border opportunities and expertise.
  4. The transatlantic fund seeks to foster ambitious founders' growth, both domestically and internationally.
  5. Alex Trewby, CEO of Apian, a Meridian Health Ventures' portfolio company, expresses gratitude for the firm's support.
  6. Apian's mission reaches globally, collaborating with Zipline and Wing, and delivering care faster to patients.
  7. Partners in the fund include leading health systems, venture investors, institutional investors, and academic centres of excellence.
  8. Guy's and St Thomas' NHS Foundation Trust, King's College Hospital, University College London Hospitals, Cedars-Sinai Medical Center, and Hartford HealthCare are some notable partners.
  9. Cedars-Sinai views the partnership as directly aligned with its mission to offer superior care worldwide.
  10. Companies in the fund's portfolio are already collaborating with US health system partners, such as Cedars-Sinai.
  11. The fund's goal is to accelerate the growth of innovative health tech startups, benefiting the NHS's patients and workforce, as well as the wider UK economy.
  12. The Meridian Health Ventures team comprises entrepreneurs, investors, operators, regulators, industry leaders, academics, and clinicians.
  13. The fund invests in MedTech spin-outs from Cambridge, Oxford, Imperial, King's, and Southampton.
  14. Twelve NHS clinical entrepreneurs are among the company founders in the fund's portfolio.
  15. Doccla, deepc, Patchwork, Tympa Health, Apian, iFAST Diagnostics, PocDoc, Phare Health, 52 North, and MediShout are some companies in the fund's portfolio.
  16. The fund aims to help healthtech superscalers thrive in the UK and fast-track their growth in the US.
  17. Partner start-ups will have access to generate real-world data and evidence for adoption within broader healthcare environments.
  18. The partners are devoted to leveraging advancements in digital and biomedical sciences to better, faster, and fairer healthcare for all.
  19. The launch of the transatlantic fund marks Meridian Health Ventures' comprehensive initiative in fostering healthcare technology innovation.
  20. The fund was established in 2021, with a mission to benefit patients and the wider healthcare ecosystem across Europe and North America.
  21. Scientists in the environmental science field can collaborate with health tech startups to address climate change's impact on medical-conditions like chronic diseases and neurological disorders.
  22. The manufacturing industry can design and produce therapies-and-treatments, medical devices, and medications for various health issues, like cancer and respiratory conditions.
  23. The fitness-and-exercise sector can promote health-and-wellness through wearables, smart home devices, and mobile apps, catering to individuals with digestive-health, skin-conditions, and eye-health concerns.
  24. Mental-health professionals can integrate smart technologies and telehealth platforms to provide access to therapies for those suffering from mental-health issues.
  25. The finance sector can invest in small-businesses and venture-capital funds focusing on health tech startups, thus contributing to the growth of the industry.
  26. The energy sector can adopt sustainable practices to reduce the environmental impact of treatments and therapies, particularly in the realm of green energy and sustainable living.
  27. The retail sector can maintain a health-and-wellness focus by offering organic food options and eco-friendly products, supporting a holistic approach to healthcare.
  28. The entrepreneurship sector can produce innovative solutions for various medical-conditions and health issues, such as autoimmune-disorders, heart diseases, and hearing impairments.
  29. The leadership and diversity-and-inclusion movement can encourage more women and ethnic minorities to enter the field of health tech, fostering innovative and inclusive solutions for a diverse population.

Read also:

    Latest

    Navigating AI in the Workplace: A Guide for Tech Leaders

    Navigating AI in the Workplace: A Guide for Tech Executives

    AI is no longer a hypothetical future agent of disruption; it is a current, influential force transforming work, job functions, and productivity. According to a KPMG report, 87% of business decision-makers are convinced that AI agents will necessitate organizations to revamp their performance...

    This week's events carried significant importance.

    Significant events marked this week.

    Charity work persists in Switzerland, while the frequency of thunderstorms with supercells has increasing attributed to climate change, posing challenges to Lausanne's weather management